In large-scale combat operations or mass casualty events, the number of available surgeons can be the difference between life and death. To address this critical shortfall, the DARPA Surgical Competition (DSC) seeks to accelerate the development of autonomous robotic systems for trauma surgery.
The Surgical Competition calls on teams from across the world to create robotic systems capable of assisting and, eventually, independently performing complex surgical procedures in unpredictable trauma environments. The goal is to assist human surgeons, creating a force multiplier that provides "infinite" surgical capacity on demand.
Through a series of demanding trials, this competition will push the state-of-the-art in robotics, artificial intelligence, and human-machine collaboration. Participants will compete for a total of $3.5 million in prizes by demonstrating capabilities in areas such as:
The innovations spurred by the competition will not only ensure our warfighters have access to the best possible medical care on the battlefield but will also have a profound impact on civilian healthcare—from improving access to care in remote areas to providing a robust response capability for national emergencies.
This is the defining DARPA predictor.
DARPA explicitly describes its research portfolio as high-risk, high-reward R&D intended to maintain technological advantage for the United States. Its small-business guidance similarly says that low-risk, low-impact incremental improvements are typically not pursued.
A strong proposal should therefore answer:
If this technology succeeds, what capability becomes possible that is not realistically possible today?
Strong DARPA concepts often involve:
DARPA formula:
Impossible/difficult capability → breakthrough technology → major strategic effect
A technically impressive idea is not enough.
DARPA's office-wide BAAs identify technical areas where the agency is seeking ideas, and program-specific BAAs define the particular problem, objectives and requirements.
The proposal should explicitly connect:
DARPA problem → capability gap → proposed technology → measurable solution
The applicant should avoid generic statements such as:
"Our AI technology is innovative."
Instead:
"Current tactical systems cannot perform X under Y conditions. Our approach enables X under those conditions by using Z."
DARPA expects genuinely new approaches.
Its Heilmeier Catechism asks:
What is new in your approach and why do you think it will be successful?
The agency uses this framework to assess whether the risk and potential payoff justify pursuing a program.
Strong proposals may introduce:
Important distinction: sophistication ≠ novelty.
A complicated implementation of an established technology may still be incremental.
DARPA does not simply fund a broad research objective and wait for results.
Its programs commonly use phases, options and explicit objectives, with progress evaluated against stated criteria, metrics, funding availability and program goals.
For Other Transactions, DARPA specifically requires detailed milestones including:
A strong proposal should therefore define:
Baseline → technical milestone → quantitative threshold → demonstration
For example:
Current system: X
Proposed system: Y
Target improvement: Z%
Demonstration date: Month N
DARPA welcomes risk—but not uncontrolled risk.
The Heilmeier Catechism explicitly asks:
A strong DARPA proposal therefore distinguishes:
High scientific/technical risk
from
poorly understood execution risk
Good applicants identify:
The objective is not to eliminate risk; it is to show why the potential payoff justifies the risk and how the team will manage it.
DARPA evaluates whether the proposed technical team has the expertise and experience required to accomplish the proposed tasks. Existing DARPA evaluation guidance explicitly identifies technical-team expertise as part of scientific and technical merit.
A competitive team might combine:
The key is complementarity.
The proposal should demonstrate:
Person A solves problem 1 + Person B solves problem 2 + organization C provides capability 3 = credible path to the DARPA objective.
DARPA is not simply an academic research funder.
Its small-business guidance explicitly asks proposers to consider whether their work can transition to the Department of Defense/warfighter, other government agencies, or the commercial market.
A strong proposal should therefore explain:
Technology → prototype → demonstration → transition partner → operational capability
Potential transition destinations include:
DARPA's Heilmeier Catechism makes communication unusually important.
The first question is:
What are you trying to do?
And DARPA specifically says the objective should be articulated using absolutely no jargon.
The proposal should quickly communicate:
A technically brilliant proposal that takes too long to explain its central idea can lose effectiveness.
DARPA's framework explicitly asks:
A strong proposal should therefore demonstrate:
DARPA challenge solicitations can explicitly evaluate whether a proposed schedule aggressively pursues performance metrics while accurately accounting for schedule risk.
This factor is less glamorous but can be decisive.
DARPA states that conforming proposals must comply with the solicitation requirements; nonconforming proposals may be removed from consideration.
Current DARPA proposal processes also include research-security reviews for covered individuals under fundamental research proposals, including assessment of certain foreign-affiliation/foreign-influence risk factors.
Other practical requirements can include:
For U.S. and international organizations, the exact eligibility requirements depend on the particular solicitation.
The goal is to assist human surgeons, creating a force multiplier that provides "infinite" surgical capacity on demand.
Sponsor Institute/Organizations: Defense Advanced Research Projects Agency
Sponsor Type: Corporate/Non-Profit
Address: 4075 Wilson Blvd. Suite 201 Arlington, Va.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Oct 30, 2026
$3,500,000
Affiliation: Defense Advanced Research Projects Agency
Address: 4075 Wilson Blvd. Suite 201 Arlington, Va.
Website URL: https://www.darpa.mil/research/challenges/surgical
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.